申请人:Glytech, Inc.
公开号:EP2752425A1
公开(公告)日:2014-07-09
[Problem] To provide a glycosylated polypeptide having affinity to somatostatin receptors and, compared to somatostatins, having improved in-blood stability.
[Solution] The glycosylated polypeptide is characterized by at least two amino acids in a somatostatin or an analogue thereof being replaced by glycosylated amino acids.
[问题]提供一种糖基化
多肽,该
多肽对体
生长抑素受体具有亲和力,并且与体
生长抑素相比,具有更好的血内稳定性。
[解决方案]糖基化
多肽的特征是,体
生长抑素或其类似物中至少有两个
氨基酸被糖基化
氨基酸取代。